Synapsoft logo
AI Insights from Disclosures
Searching...
IMBdx, Inc. 461030
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
IMBdx, Inc. is a global healthcare company that challenges cancer by enabling patient-tailored precision medicine and early diagnosis across the entire cancer life cycle, based on its innovative liquid biopsy technology. The company's main business areas consist of three fields: precision diagnosis and treatment of advanced cancer, early detection of post-surgical recurrence, and early cancer diagnosis.
Representative Director Kim Taeyu
Founded July 5, 2018
Corporation Type KOSDAQ
Industry Classification Research and experimental development on natural sciences and engineering
Corporate number 11011-6801206
Business number 256-86-01187
Phone Number 02-6951-2906
Fax Number 02-6947-3705
Website www.imbdx.com/
Company Address 131 Gasan digital 1-ro, Geumcheon-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant